This 1-hour, webinar is part of 4 four-session webinar series that will translate clinical guidelines into actionable strategies for safer benzodiazepine tapering. This webinar includes expert-led discussions and case-based applications that will cover Considerations for Tapering Benzodiazepine in Primary Care.

This 75-hour on-demand conference includes 64 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the modern landscape of psychedelics, including the local policy context with Colorado's Natural Medicine Act, reports on clinical intersections with addiction medicine, surveillance tools and data on existing community use, to better contextualize trends in acute and chronic harms, as well as potential therapeutic uses for this class of substances.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the current fentanyl-xylazine landscape, identification of related skin and soft tissue injuries, and effective approaches to wound care management.

This 75-minute on-demand session from the ASAM 56th Annual Conference addresses the pharmacology, epidemiology, diagnosis, and treatment of emerging intoxicating substances, including tianeptine, nitazenes, kratom, bromazolam and other novel benzodiazepines, stimulants, alpha-2 agonists, and NMDA antagonists

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 1-hour, on-demand session from the 2024 ASAM State of the Art Course outlines recent interesting findings and topics that have emerged, from differences in formulations and routes of administration to ways research may impact the future of policy.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This 16-hour, on-demand course is the essential primer for physicians preparing for the addiction medicine examination and also serves to increase other healthcare professionals' knowledge of addiction.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.